We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04142437
Brief Title: Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)

First Submitted : October 17, 2019
First Submitted that Met QC Criteria : October 25, 2019
First Posted : October 29, 2019

Last Update Submitted that Met QC Criteria : December 2, 2022
Last Update Posted : December 5, 2022